RK Capital - BIOSPECIFICS TECHNOLOGIES CO ownership

Quarter-by-quarter ownership
RK Capital ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q4 2016$3,944,000
-41.9%
70,801
-52.4%
0.82%
-38.1%
Q3 2016$6,787,000
-27.4%
148,599
-36.5%
1.32%
-21.0%
Q2 2016$9,352,000
+19.1%
234,159
+3.8%
1.67%
+28.2%
Q1 2016$7,853,000
-17.2%
225,518
+2.2%
1.30%
-21.4%
Q4 2015$9,480,000
+33.7%
220,618
+35.5%
1.66%
+27.5%
Q3 2015$7,089,000
+17.2%
162,806
+38.9%
1.30%
+18.6%
Q2 2015$6,048,000117,2061.09%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders